Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders

Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders

US Patent 11110127 · Granted Sep 7, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating SARS and treating or preventing ARDS2025
Genetically modified NK-92 cells having a safety switch2025
Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension2025
Oral pharmaceutical formulations of bitter compounds for asthma2025
Modified NK-92 cells for treating cancer2023
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2021
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2021
Oral pharmaceutical formulation for weight loss, diabetes and related disorders2020
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2020
Modified NK-92 cells for treating cancer2020
Genetically modified NK-92 cells and monoclonal antibodies for the treatment of 2019
Use of nanoparticles coated with red blood cell membranes to enable blood transf2019